{"id":1067940,"date":"2020-10-21T11:35:28","date_gmt":"2020-10-21T15:35:28","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/telo-genomics-announces-warrant-exercise-agreement\/"},"modified":"2024-08-18T11:41:09","modified_gmt":"2024-08-18T15:41:09","slug":"telo-genomics-announces-warrant-exercise-agreement","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/telo-genomics-announces-warrant-exercise-agreement.php","title":{"rendered":"Telo Genomics Announces Warrant Exercise Agreement"},"content":{"rendered":"<p><![CDATA[TORONTO, Oct.  21, 2020  (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (OTC: TDSGF)\u00a0(the \u201cCompany\u201d or \u201cTELO\u201d) is pleased to announce that it has engaged Leede Jones Gable Inc. and Mackie Research Corporation (the \u201cBrokers\u201d) to solicit and facilitate, on a commercially reasonable efforts basis, the exercise of warrants issued pursuant to the Company\u2019s financing announced November 25th, 2019 (the \u201cWarrants\u201d). TELO has 8,677,500 Warrants outstanding with an exercise price $0.20 per share which expire on November 25th, 2020. In connection with the engagement, the Brokers will be paid a fee of 4% of the gross proceeds received by TELO from the exercise of the Warrants.]]><\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/10\/21\/2111875\/0\/en\/Telo-Genomics-Announces-Warrant-Exercise-Agreement.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Telo Genomics Announces Warrant Exercise Agreement\">Telo Genomics Announces Warrant Exercise Agreement<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See original here: Telo Genomics Announces Warrant Exercise Agreement <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/telo-genomics-announces-warrant-exercise-agreement.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067940","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067940"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067940"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067940\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}